Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

16

Revenue 2017

Shire

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Shire's 2013 CNS, immunology and metabolic's sales performance.

Shire

Pfizer takeover rumour ignites Amarin shares

Pfizer takeover rumour ignites Amarin shares Shire acquisition and Bristol-Myers Squibb’s $74bn Celgene takeover, after failing to reach terms with AstraZeneca a few years ago.

EMA sees approval numbers rise in 2018

EMA sees approval numbers rise in 2018 These were Roche’s Hemlibra, Shire’s Takhzyro, Alnylam’s Onpattro and Tegsedi. US shutdown and Brexit.

BMS and Celgene announce $74bn merger

BMS and Celgene announce $74bn merger The deal eclipses another big M&A deal, the $62bn takeover of Shire by Takeda, which began in 2018 and is expected to be formally completed with the next few days.

Shire bags US approval for constipation drug Motegrity

Shire bags US approval for constipation drug Motegrity Approval is boost as Takeda takeover nears completion. Shire has the US approval it needs for Motegrity, a drug for chronic idiopathic constipation (CIC) that will compete with drugs like ... The approval for the new product comes as Shire is just about

Takeda secures investor backing for £46bn Shire takeover

Takeda secures investor backing for £46bn Shire takeover Weber is adamant that Shire will help Takeda grow outside Japan, swelling the company’s pipeline in the process. ... Weber said: “We are delighted that our shareholders have given their strong support to our acquisition of Shire.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics